Beginner Dose: For beginners, it is advisable to start at the lower end (2040 mcg/day) to assess tolerance and minimize side effects
If a step is rough, the trial protocols themselves allowed holding it for an extra 4 weeks or dropping back one level
The FDA dose escalation schedule in units The FDA approved a specific dose escalation protocol for tirzepatide
doi:10.1080/10408398.2018.1458021
Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial
Methods Narrative review of mechanistic pathways and randomized trials of GLP-1 receptor agonists (GLP-1RA), DPP-4 inhibitors, and newer dual/triple agonists, with targeted updates from recent pivotal programs (SELECT, FLOW, SOUL, SURPASS-CVOT) and emerging oral small-molecule GLP-1R agonists